-
1
-
2
-
3
An annotated near-complete sequence assembly of the Magnaporthe oryzae 70-15 reference genome
Published 2025-05-01Get full text
Article -
4
Corrigendum to “Automatic Segmentation and Enhancement of Pavement Cracks Based on 3D Pavement Images”
Published 2020-01-01Get full text
Article -
5
Mechanism of Scavenging Reactive Oxygen Radicals of Tea catechins
Published 2002-09-01Get full text
Article -
6
-
7
Research on Three-Phase Unbalanced Commutation Strategy Based on the Spotted Hyena Optimizer Algorithm
Published 2022-01-01Get full text
Article -
8
-
9
-
10
Identity-based fully homomorphic encryption from learning with error problem
Published 2014-02-01Get full text
Article -
11
Scalable and lightweight deep learning for efficient high accuracy single-molecule localization microscopy
Published 2025-08-01Get full text
Article -
12
-
13
-
14
-
15
Exosomes as Crucial Players in Pathogenesis of Systemic Lupus Erythematosus
Published 2022-01-01Get full text
Article -
16
-
17
-
18
Demonstration of the presence of the "deleted" MIR122 gene in HepG2 cells.
Published 2015-01-01Get full text
Article -
19
-
20
Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study
Published 2025-05-01“…Yue Fei,1 Zhihong Xie,2 Yuanyuan Luo,3 Xiaolan Yong,4 Na Li,1 Rong Huang,1 Xiaolin Du,4 Yijing Zhu,4 Dongmei Lan,3 Yang Qi,3 Gang Cheng,1 Quanren Wang,1 Kai Shen1 1Department of Clinical Research, Jiangsu Hengrui Pharmaceuticals, Shanghai, People’s Republic of China; 2Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China; 3Phase I Clinical Trial Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China; 4Phase I Clinical Trial Center, Chengdu Xinhua Hospital, Chengdu, People’s Republic of ChinaCorrespondence: Kai Shen, Department of Clinical Research, Jiangsu Hengrui Pharmaceuticals, 1288 Haike Road, Shanghai, People’s Republic of China, Email shenkai66@126.comPurpose: HRS-1780 is a selective non-steroidal mineralocorticoid receptor antagonist developed for the treatment of chronic kidney disease. …”
Get full text
Article